SEC Filings

 
SEC Filings
Date Filing Description View
May 5, 2016 CT ORDER confidential treatment order HTML PDF
9.2 KB
Add to Briefcase
May 4, 2016 4 verguet, patrick b HTML PDF XLS
154.7 KB
Add to Briefcase
May 3, 2016 4 mussallem, michael a HTML PDF XLS
157.8 KB
Add to Briefcase
Apr 29, 2016 10-Q quarterly report HTML PDF XLS XBRL
722.2 KB
Add to Briefcase
Apr 26, 2016 8-K current report HTML PDF XLS
243.7 KB
Add to Briefcase
Apr 6, 2016 4 wang, huimin HTML PDF XLS
156.9 KB
Add to Briefcase
Apr 5, 2016 4 mussallem, michael a HTML PDF XLS
154.8 KB
Add to Briefcase
Mar 31, 2016 DEFA14A definitive additional proxy materials HTML PDF XLS
229.0 KB
Add to Briefcase
Mar 31, 2016 DEF 14A definitive proxy statement HTML PDF XLS
954.5 KB
Add to Briefcase
Mar 23, 2016 3 loranger steven r HTML PDF XLS
187.9 KB
Add to Briefcase
1
...
NextLast
= add PDF file to Briefcase
News & Events
Corporate Governance
Financial Information
Stock Info & Tools
Edwards Lifesciences 2015 Investor Conference

CONTACTS

General Investor Relations

investor_relations@edwards.com
phone: (949) 250-2806
fax: (949) 250-2248

Investor Relations Team

David K. Erickson
Vice President, Investor Relations
phone: (949) 250-6826

 

Tammy Perry
Sr. Manager, Investor Relations
phone: (949) 250-2752

 

Lidia Mootz
Manager, Investor Relations
phone: (949) 250-2893

Proxy and Stock Certificate Questions

Computershare Shareholder Services
P.O. Box 43010
Providence, RI 02940
www.computershare.com
phone: (800) 446-2617


Stock Transfer Agent
Information Request

Submit questions for the Investor Relations Department.
Submit

Email Alerts Subscription

Get news delivered straight to your inbox.
Subscribe

Back to top